MYC and medulloblastoma: The meta-analysis data also show that prognostic factors like metastatic stage, histology, MYC and MYCN amplifications, 10q loss, 17p loss, and 17q gain, previously reported for medulloblastoma as a single disease [11, 12, 17], remain prognostic in these combined series of all patients.